Annotated Medicine and Device Lists


P-aminosalicylic acid

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines 2019 6.2.5. Antituberculosis medicines Others observations:
Reserve second-line drugs for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control.
PAHO Strategic Fund Medicine List 2.3. Antituberculosis med. No observations
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 04 ANTIMICOBACTERIAS No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations
El Salvador - 2019 ANTIMICOBACTERIANOS No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines 2019 6.2.5. Antituberculosis medicines Others observations:
Reserve second-line drugs for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control.
PAHO Strategic Fund Medicine List 2.3. Antituberculosis med. No observations
El Salvador - 2019 ANTIMICOBACTERIANOS No observations

Information Resources: P-aminosalicylic acid

Loading ...
Loading ...
Loading ...
No information available